Mimedx (MDXG) Capital Expenditures (2011 - 2026)
Mimedx (MDXG) reported Capital Expenditures of $570000.0 for Q1 2026, up 51.19% on a YoY basis from $377000.0 in Q1 2025, and up 100.0% sequentially from $285000.0 in Q4 2025.
Mimedx (MDXG) Capital Expenditures (2011 - 2026) Analysis & Trends
Mimedx (MDXG) has 16 years of Capital Expenditures data on file, last reported at $570000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 51.19% year-over-year to $570000.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 33.84% YoY), and the FY2025 full-year result was $1.0 million, down 38.62% from the prior year.
- Capital Expenditures improved to $570000.0 in Q1 2026, from $285000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $2.0 million in Q4 2023 to a low of -$932000.0 in Q3 2023.
- A 5-year average of $424187.5 and a median of $317000.0 in 2022 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 197.9% in 2023, while the deepest fall reached 367.05% in 2023.
- Tracing MDXG's Capital Expenditures over 5 years: stood at $667000.0 in 2022, then surged by 197.9% to $2.0 million in 2023, then tumbled by 86.76% to $263000.0 in 2024, then increased by 8.37% to $285000.0 in 2025, then surged by 100.0% to $570000.0 in 2026.
- Business Quant data shows MDXG's Capital Expenditures at $570000.0 in Q1 2026, $285000.0 in Q4 2025, and $192000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 786,000.00 |
| 10 | Mimedx | 635.35 Mn | 475.58 Mn | 41.62 Mn | 570,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 570,000.00 |
| Mar 31, 2026 | 570,000.00 |
| Dec 31, 2025 | 285,000.00 |
| Dec 31, 2025 | 285,000.00 |
| Sep 30, 2025 | 192,000.00 |
| Sep 30, 2025 | 192,000.00 |
| Jun 30, 2025 | 179,000.00 |
| Jun 30, 2025 | 179,000.00 |
| Mar 31, 2025 | 377,000.00 |
| Mar 31, 2025 | 377,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Dec 31, 2024 | 263,000.00 |
| Sep 30, 2024 | 171,000.00 |
| Sep 30, 2024 | 171,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Dec 31, 2023 | 1.99 Mn |